Angelyn Bethel
Overview
Explore the profile of Angelyn Bethel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonora E, Frias J, Tinahones F, Van J, Malik R, Yu Z, et al.
Diabetes Obes Metab
. 2021 Jun;
23(10):2242-2250.
PMID: 34189841
Aim: To evaluate the impact of dulaglutide 3.0 and 4.5 mg versus 1.5 mg on body weight in patients with type 2 diabetes (T2D) based on exploratory analyses of the...
2.
Cukierman-Yaffe T, Gerstein H, Colhoun H, Diaz R, Garcia-Perez L, Lakshmanan M, et al.
Lancet Neurol
. 2020 Jun;
19(7):582-590.
PMID: 32562683
Background: Diabetes is an independent risk factor for cognitive impairment. We aimed to investigate the association between the glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide and cognitive impairment as an exploratory...
3.
Haynes R, Judge P, Staplin N, Herrington W, Storey B, Bethel A, et al.
Circulation
. 2018 Jul;
138(15):1505-1514.
PMID: 30002098
Background: Sacubitril/valsartan reduces the risk of cardiovascular mortality among patients with heart failure with reduced ejection fraction, but its effects on kidney function and cardiac biomarkers in people with moderate...